- Study protocol
- Open Access
Mitigating structural racism to reduce inequities in sepsis outcomes: a mixed methods, longitudinal intervention study
BMC Health Services Research volume 22, Article number: 975 (2022)
Sepsis affects 1.7 million patients in the US annually, is one of the leading causes of mortality, and is a major driver of US healthcare costs. African American/Black and LatinX populations experience higher rates of sepsis complications, deviations from standard care, and readmissions compared with Non-Hispanic White populations. Despite clear evidence of structural racism in sepsis care and outcomes, there are no prospective interventions to mitigate structural racism in sepsis care, nor are we aware of studies that report reductions in racial inequities in sepsis care as an outcome. Therefore, we will deliver and evaluate a coalition-based intervention to equip health systems and their surrounding communities to mitigate structural racism, driving measurable reductions in inequities in sepsis outcomes. This paper presents the theoretical foundation for the study, summarizes key elements of the intervention, and describes the methodology to evaluate the intervention.
Our aims are to: (1) deliver a coalition-based leadership intervention in eight U.S. health systems and their surrounding communities; (2) evaluate the impact of the intervention on organizational culture using a longitudinal, convergent mixed methods approach, and (3) evaluate the impact of the intervention on reduction of racial inequities in three clinical outcomes: a) early identification (time to antibiotic), b) clinical management (in-hospital sepsis mortality) and c) standards-based follow up (same-hospital, all-cause sepsis readmissions) using interrupted time series analysis.
This study is aligned with calls to action by the NIH and the Sepsis Alliance to address inequities in sepsis care and outcomes. It is the first to intervene to mitigate effects of structural racism by developing the domains of organizational culture that are required for anti-racist action, with implications for inequities in complex health outcomes beyond sepsis.
Sepsis (a life-threatening organ dysfunction caused by a dysregulated host response to infection) affects almost 2 million patients in the US annually [1,2,3,4], is one of the leading causes of mortality (nearly 350,000/year)  and is a major driver of healthcare costs ($62 billion/year) [5, 6]. Substantial racial inequities in sepsis care and outcomes exist. African American/Black (AA/B) and LatinX populations experience higher rates of complications, deviations from standard care, and sepsis readmissions compared with Non-Hispanic White (NHW) populations . These inequities are not attributable to differences in genetic susceptibility, clinical needs, or patient preferences . Structural racism is defined as “a system in which public policies, institutional practices, cultural representations, and other norms work in various, often reinforcing ways to perpetuate racial group inequity.”  Structural racism compounds factors at the hospital and community levels to generate far poorer sepsis care and outcomes for AA/B and LatinX patients [8, 10, 11]. Racial inequities are observed at all stages in the sepsis care pathway, from primary prevention to care after discharge, stemming from the triple burden [12, 13] of increased incidence of sepsis, socioeconomic disadvantage, and lower quality care [8, 14,15,16,17,18,19,20]. Sepsis Alliance, the nation’s first and leading sepsis organization, has emphasized the urgency of addressing racial inequities in sepsis care, prioritizing this issue in its mission and issuing a national call to action .
Despite clear evidence of the role that structural racism plays in driving inequities in sepsis outcomes , there are no evidence-based, prospective interventions to mitigate structural racism in sepsis care, nor are we aware of studies that report reductions in racial inequities in sepsis care as an outcome. Current clinical quality improvement efforts in sepsis care focus largely on early detection and protocol-driven treatment with well-established care bundles ; however, none of these include racial inequities as an outcome . Further, “intervention research has rarely emphasized reduction of SRD as a strategy to reduce disparities” , and we are aware of no studies that engage health systems and community partners to address structural racism as a driver of inequities in sepsis. Realizing the full potential of recent major advances in basic science that improve identification and treatment of sepsis  will require collective action across health systems and community institutions using adaptive leadership  to create anti-racist systems change. 
Therefore, we aim to adapt, deliver, and evaluate a 2.5-year, coalition-based leadership intervention in eight U.S. health systems and their communities to improve the domains of organizational culture that are required to mitigate structural racism in sepsis care. We will adapt a proven intervention  that will develop and support Guiding Coalitions as they work to mitigate structural racism as a driver of racial inequities in sepsis care in their local context. We hypothesize that the intervention will generate longitudinal improvement in the domains of organizational culture that are required to mitigate structural racism in sepsis care. Using a longitudinal, convergent mixed methods approach we will: 1) quantify change in domains of organizational culture using a novel survey adapted from our previously validated instrument  (an innovation in measurement of structural racism), and 2) describe the experience of change within each system, integrating quantitative and qualitative data to develop a comprehensive understanding of impact and the mechanisms by which impact may have occurred. We also hypothesize that hospitals that demonstrate improvements in organizational culture will also demonstrate greater reductions in racial inequities in three sepsis-related outcomes: a) early identification (time to antibiotic), b) in-hospital mortality, and c) 30-day, all-cause hospital readmission, using comparative interrupted times series (ITS) analysis. The purpose of this paper is to present the theoretical foundation for the study, summarize key elements of the intervention, and describe in detail the study methodology to evaluate the intervention.
Coalition-based organizational change
Our team’s prior seminal work (the Leadership Saves Lives/LSL study), a novel, evidence-based organizational culture change intervention that focused on 30-day risk-standardized mortality rates (RSMR) for acute myocardial infarction (AMI), provides a robust foundation for the proposed study . We intervened in 10 US hospital systems drawn from the Mayo Clinic Care Network (MCCN), working for 2 years with Guiding Coalitions (e.g., a wide range of clinicians, administrators and others both within and outside of the hospital), to reduce RSMR for AMI through improving key domains of organizational culture (i.e., learning and problem solving, senior management support, psychological safety). The 6 hospitals that demonstrated substantial shifts in culture showed a significantly greater decrease in RSMR than the 4 hospitals that did not experience such culture changes (RSMR reduced by 1.07 percentage points and 0.23 percentage points, respectively; P = 0.027). The evidence generated through LSL demonstrates that a coalition-based leadership intervention can change organizational culture with impact on a major clinical outcome . Mechanisms for change included collaborating across historical, political, and organizational boundaries [30,31,32]. The LSL intervention required close collaboration with organizations outside of the hospital; hospitals reported planning to ‘transfer LSL’ to other complex health outcomes such as heart failure and stroke, suggesting its broader applicability. In addition, our prior research has also shown that health system links with non-health community organizations are associated with improved readmission rates , and that efforts to generate social capital in surrounding geographies and invest in social supports such as housing and community engagement are tied to better outcomes for a number of complex health conditions [34,35,36]. We anticipate similar types of collaborations with health care and non-health care partners will be developed by Guiding Coalitions in the proposed study. Finally, our validated measure of hospital organizational culture  will be adapted to address the domains of organizational culture that are required to mitigate structural racism, another important methodological advancement of the proposed study.
Evidence of structural racism in sepsis care and outcomes
AA/B and LatinX populations have higher rates of complications leading to sepsis , deviations from standard sepsis care, higher in-hospital mortality, and higher all-cause and sepsis readmissions compared with NHW populations [7, 10]. Sepsis-related mortality for AA/B patients is nearly double that for NHWs across all age groups (rate ratio = 1.78) nationally . AA/B patients are twice as likely to die from severe infections driven by antibiotic resistance as compared to NHWs; many of these are sepsis deaths . Racial inequities are observed at all stages in the care pathway for patients at risk of sepsis. At the level of primary prevention, AA/B and LatinX people experience higher levels of chronic comorbidities, and lower rates of access to primary care [17, 19, 20], including vaccination (which reduces incidence of sepsis) . At the level of care seeking, AA/B and LatinX patients have well-justified mistrust in engaging with the health care system , demonstrate lower awareness of sepsis , receive less timely and accurate triage [18, 40], and receive lower intensity use of diagnostics and treatment (e.g., less likely to receive ICU care, longer length of stay, less frequent referral for follow-up care). AA/B patients are more likely to experience poverty and lack of insurance , both of which are associated with poorer care and outcomes along the care continuum, although many of these inequities persist when controlling for insurance status [41,42,43]. Finally, AA/B patients experience implicit bias at the provider and health care system levels; however, currently no studies examine the role of implicit bias in sepsis care [44,45,46]. Sepsis Alliance, the nation’s first and leading sepsis organization, has emphasized the urgency of addressing racial inequities in sepsis care, prioritizing this issue in its mission and issuing a national call to action .
Linking from underlying racism to clinical outcomes
The conceptual model below (Fig. 1), which we developed based on synthesis of existing evidence on race-based inequities in healthcare and outcomes, shows how racism is manifest across the sepsis care continuum, and provides a starting point for our work to measure and intervene on the domains of organizational culture that are required to mitigate structural racism [8, 14, 47,48,49,50]. At the foundational levels of the framework are ecological barriers to health equity, factors that are deeply embedded in our US society that perpetuate structural racism . Through facilitated collaboration, Guiding Coalitions will increase their home systems’ attention to these factors. The next level defines domains of organizational culture associated with organizational capacity to mitigate structural racism. These domains, derived from our own work in organizational culture change and consistent with capacity for whole systems transformation, are the capacities that will be strengthened through the proposed intervention [27, 29, 30, 32]. The next level defines ways in which structural racism impacts the sepsis care pathway, moving from risk and primary prevention on the left to standards-based follow up care on the right. Participating sites will use their own data to name and prioritize the inequities most salient in their own systems and apply a proven strategic problem-solving process  to understand and address these symptoms of structural racism. Finally, at the highest level, we will measure the impact of these changes on racial inequities in care and outcomes for patients with sepsis.
We will employ a robust, longitudinal mixed methods interventional study design that includes three aims: delivery of the intervention, evaluation of the impact of the intervention on organizational culture, and evaluation of the impact of the intervention on racial inequities in care and outcomes for patients with sepsis (Additional File 1: Supplemental Fig. 1). The study is projected to take place over a 5-year project period (Fig. 2). This description of the intervention and the associated evaluation has been prepared in alignment with the StaRI standards for the reporting of implementation studies (Additional File 2) .
Site selection and intervention (Aim 1)
Overview: We will adapt and deliver a coalition-based leadership intervention in eight U.S. health systems and their surrounding communities to improve domains of organizational culture that are required to mitigate structural racism, with reducing racial inequities in sepsis care and outcomes as a shared goal. We will support these eight health systems to establish Guiding Coalitions made up of administrative and clinical leadership involved in sepsis care, patient advocacy representatives, and community organizations poised to address the impact of structural racism through collaboration. We will engage these coalitions in a 2.5 year, facilitated leadership intervention grounded in double-loop learning [27, 54, 55] to apply a strategic problem-solving method  to measure, understand, and address structural racism as a driver of racial inequities in sepsis care in their local context.
Health systems and their surrounding communities will be recruited from the membership of the MCCN, a group of independent health systems that purchase access to Mayo Clinic's tools and expertise, and that are vetted and selected for their commitment to high-quality patient experience and outcomes. These members represent all four census regions and all nine census divisions, serving sufficiently diverse patient populations to demonstrate the changes in racial inequities anticipated through the proposed work. We will use random sampling with a purposeful component  to select sites that include at least 5% proportion of AA/B clients and are diverse in geography and teaching status. Of MCCN’s 37 domestic (US) members, approximately 20 have a minimum patient population greater than 5% AA/B [average 12%]. We will work with each site to establish a Guiding Coalition  that represents the components of the system (within and beyond the health sector) required to address the impact of structural racism on sepsis care and outcomes (Table 1). Each site will be asked to name four core coalition members who will serve as senior champions for the project representing health systems administration, clinical leadership, and community engagement. These core members will participate in the cross-hospital forums and will lead the creation of the full coalition in their site, adapting guidance for coalition membership and structure to their unique context.
Based on our prior success in similar organizational change efforts , the 2.5 year intervention will include three components: 1) a series of five semiannual virtual, cross-site forums attended by four key members of each Guiding Coalition; 2) a series of four one-day workshops onsite with the full coalition at each hospital; and 3) a web-based platform to allow sites to share experiences and to serve as a repository for program resources. The content will build on and extend the previously published LSL curriculum . Semiannual forums will bring sites together as a learning community for advice and problem solving on culture change to address structural racism in sepsis care. The sequence of forums will move sites from understanding and ‘buying in’ to the evidence base to sharing implementation challenges and successes. In the annual and closing forums, sites will vote for the “STAR” (Striving to Achieve the Remarkable) site that best exemplifies commitment to the objectives of the learning community, a highly motivational activity in LSL. On site workshops will build leadership capacity within the full Guiding Coalition to mitigate structural racism as it manifests in sepsis care. Each of the four workshops will include one full day of content, scheduled based on site preferences. The core curriculum for the workshops will incude both how to work (improving the domains of organizational culture that are required to mitigate structural racism and the underlying ecological barriers to health equity) and what to work on (strategic problem solving  to address root causes of inequities in sepsis care and outcomes in their site, see Additional File 1; Supplemental Fig. 2 for examples). In the first workshop, we will orient Guiding Coalition members to the intervention and the evidence base, promote reflection on their own measures of inequities in sepsis care and baseline organizational culture (survey measure described below), and name a problem statement and objective on which the group will focus their root cause analysis process. We will also invest in effective working relationships and processes among coalition members, including representation and role clarity , decision-making , and accountability . Between workshops, the coalitions will be tasked with making and measuring progress toward addressing identified priority root causes of racial inequities in sepsis care in their home systems. At subsequent workshops, members will report on their progress, with the goal of solving implementation challenges and further developing their individual and group capacity for adaptive leadership [25, 26]. Additional workshop content will include diagnosing and shaping organizational culture, engaging conflict productively , using levels of analysis to diagnose organizational challenges [62, 63], and working with power and hierarchy [64, 65]. Content will be tailored to the local context by adjusting the timing of these modules to meet teams’ most pressing needs, adapting the specific examples and experiential learning exercises used in each module, articulating linkages between these content areas and ongoing work in each site, and encouraging each site to focus on root causes of inequities in sepsis care and treatment that are most salient in their environment. The facilitation team will include expert facilitators from across the United States, with backgrounds in organizational development, leadership education, anti-racist organizational change, and clinical quality improvement; most facilitators will be drawn from a faculty pool with deep experience developed through prior successful projects. Facilitators will work in teams of two or three, including a lead facilitator and additional experts tailored to the needs of each site. To promote standardization across sites while allowing for adaptation to local context, facilitators will use a fidelity checklist for each workshop. At the end of each workshop, the lead facilitator will prepare a structured written summary of decisions and action items for report back to the Guiding Coalition and to the full facilitation team. Between workshops, a web-based information sharing platform will serve two primary functions: (1) to serve as an accessible, up-to-date repository of project materials and references and (2) to support direct communication across hospital teams for sharing of successes, barriers, and project updates.
Evaluation of impact on organizational culture (Aim 2)
The intervention will be evaluated using a robust, longitudinal mixed-methods design (additional file 1: supplemental Fig. 3). First, we will evaluate the impact of the intervention on the domains of organizational culture that are required to mitigate structural racism in care of patients with sepsis. As is recommended for evaluating complex interventions , we propose a convergent, longitudinal mixed methods design  (Fig. 3), with: 1) a novel survey instrument (quant), 2) in-depth interviews (qual) and 3) ethnographic observations (qual) , integrating quantitative and qualitative data at the analysis phase to develop a comprehensive understanding of intervention impact on organizational culture and mechanisms by which the impact may have occurred.
All Guiding Coalition members at each system (n = 8 x ~ 15 members = 120) will be invited to participate in a survey using a novel instrument drawn from previously validated scales (Additional File 3) , which includes 30 items within 4 domains: learning and problem solving, senior leadership support, structures and processes that support change, and psychological safety. Example item: “We have goals and metrics in place to guide our efforts to reduce racial inequities in care of patients with sepsis.” Responses will be entered using the sliding bar function in Qualtrics, with anchors “never” to “always.” To ensure that our instrument captures new concepts related to anti-racist practice, we will conduct cognitive interviews [70, 71] (n = 8–10) with respondents similar to Guiding Coalition members, and revise our draft instrument as needed [28, 72,73,74,75]. Participants will complete the secure, web-based survey at the launch, midpoint and end of the intervention. To assess changes in 4 domains of organizational culture and overall, we will use hierarchical generalized linear modeling to estimate the association between mean scores and time, accounting for clustering of individual respondents within systems. We will use statistical analysis to determine significant changes at the level p < 0.05 for overall culture and each of the 4 domains for each system and the full sample. Analyses will be conducted using SAS V.9.4 and independently corroborated by two analysts. In addition to assessing the impact of the intervention in this study, the survey will be the first (to our knowledge) to measure aspects of organizational culture required for anti-racist systems change.
Interviews and observations
In-depth, in-person interviews will be conducted by trained members of the research team with different disciplinary backgrounds, using a standard interview guide (Additional File 4), beginning with a grand tour question : “Tell me about your experiences in working to address racial inequities in sepsis care,” with structured probes to encourage participants to describe specific examples or vignettes. The sample will include Guiding Coalition members and additional key informants  as needed to achieve thematic saturation  at each site. As is typical with in-depth interviewing , we anticipate interviews will be approximately 1 h in length. Interviews will be audiotaped and transcribed by independent, professional transcriptionists to enhance data reliability. At each site, we will also observe 2–8 h of daily routines in relevant community and hospital settings tailored to the sepsis project at each site.
Observations will be completed by an experienced researcher using a standard observation template (Additional File 5) [79, 80] including context, stakeholders, and events, synthesized as field notes at the completion of the site visit. Intervention teams will participate in a debriefing session immediately upon return from site visits; reflections will be included in the qualitative data set for analysis. Analysis: Transcribed interview and ethnographic data will be analyzed by a 5-person multidisciplinary team using the constant comparative method of qualitative data analysis . Coding of the data will include a series of iterative steps, beginning with an initial ‘start list’ of codes  to be refined during analysis of transcripts from subsequent interviews. We will conduct iterative coding and analysis with each wave of data collection, using negotiated consensus to resolve differences in interpretation, until a final code structure is established . We will implement longitudinal analysis using matrices (rows = single case, group or theme, columns = time) to uncover patterns and interrelationships in change over time within and across health systems . Data will be entered into ATLAS.ti to facilitate analysis. We will systematically search for disconfirming evidence , interview multiple participants in each health system for triangulation , and maintain a detailed audit trail to document analytic decisions . To our knowledge, this will be one of the largest longitudinal qualitative data sets in the country , and could support sub-investigations on the nature of structural racism and health [31, 86].
Integration will be accomplished through merging in a mixed methods matrix [69, 87] at the final stage of analysis (Additional File: 1 Supplemental Fig. 4). For each site, we will integrate quantitative trend data (overall and by each domain of the survey) and qualitative data. We will classify each site as having positive or no change based on meeting either quantitative (statistically significant change in overall readiness score from baseline to follow up) or qualitative criteria (marked shift in culture characterized by substantial, consistent, specific illustrations of notable changes in three to four of the domains of culture and little to no disconfirming evidence). We will use comparative analysis to describe differences between the systems that achieve substantial change and those that do not. Finally, we will examine differences in clinical outcomes as described in Aim 3 below. Note: analysts will be blinded to all clinical outcomes data during this analysis.
Evaluation of impact on racial inequities in sepsis care (Aim 3)
We will evaluate the impact of the intervention on racial inequities in three sepsis-related outcomes: a) early identification (time to antibiotic), b) in-hospital mortality, and c) 30-day hospital readmission, using comparative interrupted times series (ITS) analysis. Time to Antibiotics: We will use hospital EHR data to determine the difference in mean time from hospital arrival to first antibiotic administration for all AA/B patients and NHW patients and between LatinX and NHW patients respectively presenting with sepsis. This value will be calculated quarterly. We will use t-tests to measure statistically significant differences between AA/B and NHW patients, and LatinX and NHW patients. A clinically meaningful difference in mean time to antibiotic would be 30 min [88,89,90,91,92,93]. In-Hospital Mortality: We will use hospital EHR data to determine the difference in quarterly in-hospital mortality rate by 30 days for AA/B and NHW patients and LatinX and NHW patients admitted for sepsis. Rates will be standardized by age and sex . At each time point, we will use t-tests to measure statistically significant differences between AA/B and NHW patients, and LatinX and NHW patients. Currently, the rates of in-hospital mortality for AA/B are nearly double those of NHWs, and although the overall rates of sepsis mortality have remained relatively stable over the past decade, this gap has persisted . A clinically meaningful difference in rates of in-hospital mortality would be greater than 1%. 30-Day Hospital Readmission: We will use hospital EHR data to determine the difference in quarterly 30-day, same-hospital, all-cause readmission rate for AA/B patients and NHW patients, and LatinX and NHW patients with an index hospitalization for sepsis. Rates will be standardized by age and sex. We will use t-tests to measure statistically significant difference between AA/B and NHW patients, and LatinX and NHW patients. A clinically meaningful difference in rates of 30-day readmission would be 5% . Sepsis Case Identification: We will identify hospital admissions for sepsis using validated International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis procedure codes for infection and organ failure. This strategy , known as the Dombrovskiy strategy, is more sensitive than methods that use only ICD-9-CM codes for sepsis  and will allow the investigative team to include patients with sepsis that may have otherwise been missed by chart review that would still be eligible for evidence-based practices. For each health system, we expect to be able to observe at least 140 AA/B patients with sepsis each year (within a sample of MCCN member health systems, average inpatient volumes are over 19,000, patient population is approximately 12% AA/B, and nationally, sepsis is present in 6% of adult hospitalizations) ; therefore, we anticipate being able to track enough cases within each health system for each clinical outcome at each quarter.
We will conduct a comparative interrupted times series (ITS) analysis to examine the relation between the intervention and racial/ethnic differences in sepsis clinical outcomes between AA/B and NHW patients and between LatinX and NHWs. The analysis will be performed separately for our three key outcomes: 1) time to antibiotics, 2) in-hospital mortality, and 30-day readmission and stratified by response to the intervention (change/no change) (Additional File 1; Supplemental Fig. 5). We will consider a pre-exposure to the intervention time beginning 2.5 years (10 quarters) prior to starting the intervention and a postexposure period comprising 2.5 years (10 quarters) following the start of the intervention, with estimates made at every calendar quarter. ITS will be utilized to determine the difference in quarterly rates over time between changers (systems that responded to the intervention) and non-changers, health systems that did not respond to the intervention. Subsequently, ITS allows us to detect if an intervention has impact above and beyond secular trends when randomization is not a feasible option, and is ideal for evaluation of data collected across multiple equally spread time points by testing the changes in the slope of an outcome over time . Additionally, ITS requires at least eight observations pre and post intervention . We will utilize generalized mixed effect models in conjunction with segmented regression to evaluate the effectiveness of our intervention . The model will control for patient-level characteristics, including age, sex, insurance status, Charlson Comorbidity index, and admission through the Emergency Department or transfer from another acute care facility, and hospital-level characteristics including size, academic vs community hospital, number of intensive care beds, annual sepsis case volume. We will also account for seasonality based on calendar quarter by including a “season” term alone and interacted with the treatment indicator and will assess for any residual autocorrelation using autoregressive integrated moving average (ARIMA). To allow a marginal interpretation of results, we will use a linear probability model for all analyses. Because outcomes of patients within a hospital are expected to be correlated, we will account for these non-standard variance–covariance structures by clustering at the hospital level. All coefficients will be modeled as fixed effects.
To our knowledge this is the first study to evaluate the impact of cultural change on racial inequities in care for patients with sepsis. Aligned with NIH and NIGMS priorities, the results of this study are expected to: 1) further the nascent scientific literature on conceptualizing and measuring structural racism and health outcomes, 2) generate community-driven innovations in sepsis care for dissemination through national organizations such as American College of Chest Physicians, and 3) provide much-needed evidence to inform local and national dialogue around structural racism and health. We fully recognize this study is an audacious proposition. It not only addresses a highly sensitive topic (structural racism), but it also seeks to make measurable change in the structural root causes of inequities in sepsis care. Importantly, we have balanced our ambitions for whole system change with careful operationalization of core constructs and detailed measurement approaches to understand the mechanisms of change. Further, the proposed study may be especially audacious in the context of COVID-19, which will likely strain organizational capacity to participate in change initiatives and is expected to change patient care processes and outcomes. As described above, a period of systematic stakeholder engagement will allow us to adapt the intervention for feasibility in the ever-changing context of COVID-19. Further, given the well-document impact of the pandemic in exposing structural racism and exacerbating racial inequities, the proposed study is both timely and urgent.
We have anticipated several potential limitations in the proposed methodology. First, to mitigate social desirability bias (participants reporting socially acceptable, rather than authentic, responses) , we will use established techniques including attention to our own positionality and engagement of a diverse research team, engagement of a wide range of key informants across the project, use of interview guides with scripted probes to elicit details that would be difficult to misrepresent, encouraging participants to share both positive and negative experiences, and cultivating longitudinal relationships to encourage candor [100,101,102]. Second, clinical outcomes data will be derived from the EHR, which is known to have high rates of missing or misclassification of socially assigned race. Although this is concerning, 1) evidence indicates that EHR-based clinical data provides more objective estimates than claims-based data for sepsis surveillance , 2) any bias is likely toward the null (as most errors are of identifying LatinX patients as NHW) [103,104,105] and 3) there is no alternative. Further, we anticipate that some sites may use this project as an opportunity to highlight and correct for historical underinvestment in systematic, reliable capture of socially assigned race and other important demographics in their EHR. Third, Coalition turnover is expected to occur, limiting paired analyses of quantitative data. However, our prior research found that neither coalition size nor turnover was associated with intervention outcomes  (an association that we will evaluate in the proposed study as well). Further, organizations that were more successful in driving changes in organizational culture were observed to proactively adjust their coalition membership to adapt to changes in organizational leadership, to engage emerging champions, and to account for the specific aspects of AMI care they were addressing. Additionally, our study is designed to measure systems-level (rather than individual-level) phenomena, and we anticipate that the roles represented on the coalitions will remain relatively stable even as individuals come and go. Fourth, as with all health interventions there is a lag in time between implementation of practice change and corresponding adjustments in outcome rates. Subsequently, we plan to track difference in AA/B and NHW patients and LatinX and NHW patients for each of our clinical outcomes for 2.5 years post intervention implementing different lag periods (up to 6 months of lag time between the end of the intervention and time of observed clinical outcomes). Fifth, we may face limitations in attributing observed changes to the intervention. Hospitals will be exposed to multiple sources of knowledge during the intervention and may also undergo substantial internal shifts in staff and priorities. The mixed methods design of the proposed study is expected to allow us to capture and understand factors beyond the intervention that may be influencing the results.
This project is expected to provide a solid foundation for natural extensions of future work to address racial inequities in health outcomes nationally, including: 1) adapting the intervention to address other clinical conditions for which structural racism is a major influence such as diabetes and heart disease, 2) if the intervention is successful, conducting implementation science studies to determine the necessary dose and core components of the intervention to inform efforts to scale up nationally, and 3) sustaining and enhancing our productive partnership with MCCN to serve as a platform for investigation of basic science and clinical innovations in sepsis. Finally, because this is practice-informed scholarship, we anticipate that systems will generate novel strategies and tools for clinical management of sepsis. This was the case in LSL, where we received two grants to support knowledge translation and packaging of tools for AMI care generated by the study . There is a substantial opportunity to partner for practical dissemination of results and associated ‘toolkits’ through national organizations such as CHEST, Sepsis Alliance, and the Society of Critical Care Medicine.
Addressing the impact of structural racism on sepsis care will require urgent and courageous action across health systems and community institutions, supported by ways of working to collaborate effectively across historical, political, and organizational boundaries. Aligned with calls to action by the NIH and Sepsis Alliance to address inequities in sepsis care and outcomes, this paper outlines an ambitious and rigorous interventional mixed methods approach. It is the first study to intervene prospectively to mitigate effects of structural racism by developing the domains of organizational culture that are required for anti-racist action. The results of this study are expected to have implications for providers, policymakers, and other healthcare professionals committed to addressing systemic racism within and beyond care for patients with sepsis.
Availability of data and materials
Not applicable—No datasets or materials have been generated or analyzed as part of this prospective description of the study protocol.
Acute Myocardial Infarction
Electronic Health Record
Interrupted times series
Leadership Saves Lives
Mayo Clinic Care Network
Risk-Standardized Mortality Rate
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.
Buchman TG, Simpson SQ, Sciarretta KL, Finne KP, Sowers N, Collier M, et al. Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012–2018. Crit Care Med. 2020;48:276–88.
Hall MJ, Levant S, DeFrances CJ. Trends in inpatient hospital deaths: national hospital discharge survey, 2000-2010. NCHS Data Brief. 2013;(118):1–8.
Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA. 2017;318:1241–9.
Buchman TG, Simpson SQ, Sciarretta KL, Finne KP, Sowers N, Collier M, et al. Sepsis among medicare beneficiaries: 2. The trajectories of sepsis, 2012–2018. Crit Care Med. 2020;48:289–301.
Torio CM, Andrews RM. National inpatient hospital costs: the most expensive conditions by payer, 2011. 2013 Aug. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville: Agency for Healthcare Research and Quality (US); 2006. Statistical Brief #160.
Lizza BD, Betthauser KD, Juang PH, Hampton NB, Lyons PG, Kollef MH, et al. Racial disparities in readmissions following initial hospitalization for sepsis. Crit Care Med. 2021;49:e258–68.
DiMeglio M, Dubensky J, Schadt S, Potdar R, Laudanski K. Factors underlying racial disparities in sepsis management. Healthcare (Basel). 2018;6(4):133. https://doi.org/10.3390/healthcare6040133.
The Aspen Institute. Glossary for understanding the dismantling structural racism/promoting racial equity analysis. Roundtable on Community Change. https://www.aspeninstitute.org/wp-content/uploads/files/content/docs/rcc/RCC-Structural-Racism-Glossary.pdf. Accessed 15 Mar 2022.
Sepsis Alliance. Racial equity in sepsis care matters. 2021 https://www.sepsis.org/news/racial-equity-in-sepsis-care-matters/. Accessed 15 Mar 2022.
Velasco-Mondragon E, Jimenez A, Palladino-Davis AG, Davis D, Escamilla-Cejudo JA. Hispanic health in the USA: a scoping review of the literature. Public Health Rev. 2016;37:31.
Bailey ZD, Feldman JM, Bassett MT. How Structural Racism Works - Racist Policies as a Root Cause of U.S. Racial Health Inequities. N Engl J Med. 2021;384:768–73.
Beck AF, Edwards EM, Horbar JD, Howell EA, McCormick MC, Pursley DM. The color of health: how racism, segregation, and inequality affect the health and well-being of preterm infants and their families. Pediatr Res. 2020;87:227–34.
Institute of Medicine. Unequal treatment:confronting racial and ethnic disparities in health care. Smedley BD, Stith AY, Nelson AR, editors. Washington (DC): The National Academies Press; 2003
Jones JM, Fingar KR, Miller MA, Coffey R, Barrett M, Flottemesch T, et al. Racial disparities in sepsis-related in-hospital mortality: using a broad case capture method and multivariate controls for clinical and hospital Variables, 2004–2013. Crit Care Med. 2017;45:e1209–17.
Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, et al. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA. 2010;303:2495–503.
Richardson LD, Norris M. Access to health and health care: how race and ethnicity matter. Mt Sinai J Med. 2010;77:166–77.
Schrader CD, Lewis LM. Racial disparity in emergency department triage. J Emerg Med. 2013;44:511–8.
Soto GJ, Martin GS, Gong MN. Healthcare disparities in critical illness. Crit Care Med. 2013;41:2784–93.
Vogel TR. Update and review of racial disparities in sepsis. Surg Infect (Larchmt). 2012;13:203–8.
Sepsis Alliance. Sepsis Alliance invites health sector colleagues to sign equity, diversity, and inclusion pledge. 2021 https://www.sepsis.org/news/sepsis-alliance-invites-health-sector-colleagues-to-sign-equity-diversity-and-inclusion-pledge/. Accessed 15 Mar 2022.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–77.
Scheer CS, Fuchs C, Kuhn SO, Vollmer M, Rehberg S, Friesecke S, et al. Quality improvement initiative for severe sepsis and septic shock reduces 90-Day mortality: a 7.5-year observational study. Crit Care Me. 2017;45:241–52.
National Institutes of Health. Funding opportunity announcement: understanding and addressing the impact of structural racism and discrimination on minority health and health disparities 2021 [cited 2022 March 15]. Available from: https://grants.nih.gov/grants/guide/rfa-files/rfa-md-21-004.html.
Heifetz RA, Laurie DL. The work of leadership. Harv Bus Rev. 1997;75:124–34.
Came H, Griffith D. Tackling racism as a “wicked” public health problem: Enabling allies in anti-racism praxis. Soc Sci Med. 2018;199:181–8.
Curry LA, Brault MA, Linnander EL, McNatt Z, Brewster AL, Cherlin E, et al. Influencing organisational culture to improve hospital performance in care of patients with acute myocardial infarction: a mixed-methods intervention study. BMJ Qual Saf. 2018;27:207–17.
Bradley EH, Brewster AL, Fosburgh H, Cherlin EJ, Curry LA. Development and psychometric properties of a scale to measure hospital organizational culture for cardiovascular care. Circ Cardiovasc Qual Outcomes. 2017;10:e003422.
Linnander E, McNatt Z, Boehmer K, Cherlin E, Bradley E, Curry L. Changing hospital organisational culture for improved patient outcomes: developing and implementing the leadership saves lives intervention. BMJ Qual Saf. 2021;30:475–83.
Bradley EH, Brewster AL, McNatt Z, Linnander EL, Cherlin E, Fosburgh H, et al. How guiding coalitions promote positive culture change in hospitals: a longitudinal mixed methods interventional study. BMJ Qual Saf. 2018;27:218–25.
Curry LA, Brault MA, Cherlin E, Smith M. Promoting integration of pharmacy expertise in care of hospitalized patients with acute myocardial infarction. Am J Health Syst Pharm. 2018;75:962–72.
Curry LA, Linnander EL, Brewster AL, Ting H, Krumholz HM, Bradley EH. Organizational culture change in U.S. hospitals: a mixed methods longitudinal intervention study. Implement Sci. 2015;10:29.
Bradley EH, Curry L, Horwitz LI, Sipsma H, Wang Y, Walsh MN, et al. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013;6:444–50.
Bradley EH, Canavan M, Rogan E, Talbert-Slagle K, Ndumele C, Taylor L, et al. Variation in health outcomes: the role of spending on social services, public health, and health care, 2000–09. Health Aff (Millwood). 2016;35:760–8.
Brewster AL, Lee S, Curry LA, Bradley EH. Association between community social capital and hospital readmission rates. Popul Health Manag. 2019;22:40–7.
Taylor LA, Tan AX, Coyle CE, Ndumele C, Rogan E, Canavan M, et al. Leveraging the social determinants of health: what works? PLoS ONE. 2016;11: e0160217.
Bauer ME, Bateman BT, Bauer ST, Shanks AM, Mhyre JM. Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg. 2013;117:944–50.
Prest J, Sathananthan M, Jeganathan N. Current Trends in Sepsis-Related Mortality in the United States. Crit Care Med. 2021;49:1276–84.
Sepsis Alliance. 2020 Sepsis Alliance annual survey. file:///C:/Users/ejc26/Downloads/2020-Awareness-Survey-FINAL-08–28–20–1.pdf. Accessed 15 Mar 2022.
Raman J, Johnson TJ, Hayes K, Balamuth F. Racial Differences in Sepsis Recognition in the Emergency Department. Pediatrics. 2019;144.
Brown EJ, Polsky D, Barbu CM, Seymour JW, Grande D. Racial disparities in geographic access to primary care in philadelphia. Health Aff (Millwood). 2016;35:1374–81.
Lu PJ, O’Halloran A, Williams WW, Lindley MC, Farrall S, Bridges CB. Racial and ethnic disparities in vaccination coverage among adult Populations in the U.S. Am J Prev Med. 2015;49:S412-25.
Williams WW, Lu PJ, O’Halloran A, Kim DK, Grohskopf LA, Pilishvili T, et al. Surveillance of vaccination coverage among adult populations - United States, 2015. MMWR Surveill Summ. 2017;66:1–28.
Blair IV, Steiner JF, Havranek EP. Unconscious (implicit) bias and health disparities: where do we go from here? Perm J. 2011;15:71–8.
Cooper LA, Roter DL, Carson KA, Beach MC, Sabin JA, Greenwald AG, et al. The associations of clinicians’ implicit attitudes about race with medical visit communication and patient ratings of interpersonal care. Am J Public Health. 2012;102:979–87.
FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Medical Ethics. 2017;18.
Alvidrez J, Castille D, Laude-Sharp M, Rosario A, Tabor D. The national institute on minority health and health disparities research framework. Am J Public Health. 2019;109:S16–20.
Diez Roux AV. Conceptual approaches to the study of health disparities. Annu Rev Public Health. 2012;33:41–58.
Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96:2113–21.
Yearby R. Structural racism and health disparities: reconfiguring the social determinants of health framework to include the root cause. J Law Med Ethics. 2020;48:518–26.
Jones CP. Seeing the water: seven values targets for anti-racism action. Harvard medical school primary care review blog. 2020 http://info.primarycare.hms.harvard.edu/review/seven-values-targets-anti-racism-action. Accessed 15 Mar 2022.
Bradley EH, Nembhard I, Taylor L, Brewster A, Banaszak-Hall J. Leadersip and management: a frramework for action. In: Burns L, Weiner B, editors. Shortell and Kaluzny’s Health Care Management: Organization Design and Behavior. New York: Delmar Cengage Learning; 2019. p. 32–55.
Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ. 2017;356: i6795.
Argyris C. Double loop learning in organizations. Harv Bus Rev. 1977;55:115–25.
Argyris C. Double-loop learning, teaching, and research. Academy of Management Learning & Education. 2002;1:206–18.
Patton MQ, Fund RECM. Qualitative research & evaluation methods. Thousand Oaks: SAGE Publications; 2002.
Kotter JP. Leading change. Boston Mass: Harvard Business School Press; 1996.
Rizzo JR, House RJ, Lirtzman SI. Role Conflict and ambiguity in complex organizations. Adm Sci Q. 1970;15:150–63.
Schweiger DM, Sandberg WR. The utilization of individual capabilities in group approaches to strategic decision-making. Strateg Manag J. 1989;10:31–43.
Mello JA. improving individual member accountability in small work group settings. J Manag Educ. 1993;17:253–9.
Schulz-Hardt S, Jochims M, Frey D. Productive conflict in group decision making: genuine and contrived dissent as strategies to counteract biased information seeking. Organ Behav Hum Decis Process. 2002;88:563–86.
Alderfer CP. The practice of organizational diagnosis : theory and methods. New York: Oxford University Press; 2011.
Berg D. Levels of analysis: diagnosis & intervention. http://csms.org/wp-content/uploads/2015/04/Levels-Organizational-Analysis.pdf. Accessed 15 Mar 2022.
Jaques E. In praise of hierarchy. Harv Bus Rev. 1990;68:127–33.
Ronay R, Greenaway K, Anicich EM, Galinsky AD. The path to glory is paved with hierarchy: when hierarchical differentiation increases group effectiveness. Psychol Sci. 2012;23:669–77.
Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321:694–6.
Curry LA, Nunez-Smith M. Mixed methods in health sciences research : a practical primer. Thousand Oaks, CA: Sage Publications; 2015.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337: a1655.
Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs-principles and practices. Health Serv Res. 2013;48:2134–56.
Beatty PC, Willis GB. Research synthesis: the practice of cognitive Interviewing. Public Opin Q. 2007;71:287–311.
Willis GB. Cognitive interviewing : a tool for improving questionnaire design. Thousand Oaks, Calif: Sage Publications; 2005.
Bradley EH, Curry L, Horwitz LI, Sipsma H, Thompson JW, Elma M, et al. Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J Am Coll Cardiol. 2012;60:607–14.
Bradley EH, Curry LA, Spatz ES, Herrin J, Cherlin EJ, Curtis JP, et al. Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann Intern Med. 2012;156:618–26.
Brewster AL, Yuan CT, Tan AX, Tangoren CG, Curry LA. Collaboration in health care and social service networks for older adults: association with health care utilization measures. Med Care. 2019;57:327–33.
Kyanko KA, Curry LA, Busch SH. Out-of-network provider use more likely in mental health than general health care among privately insured. Med Care. 2013;51:699–705.
Miles MB, Huberman AM. Qualitative data analysis : an expanded sourcebook. 2nd ed. Thousand Oaks: Sage Publications; 1994.
Morse JM. The significance of saturation. Qual Health Res. 1995;5:147–9.
McCracken G. The long interview. Newbury Parks: Sage Publications; 1988.
Hermanowicz JC. The longitudinal qualitative Interview. Qual Sociol. 2013;36:189–208.
Schensul SL. Essential ethnographic methods : observations, interviews, and questionnaires. Stephen L. Schensul, Jean J. Schensul, Margaret D. LeCompte. LeCompte MD, Schensul JJ, editors. Walnut Creek, Calif: AltaMira Press; 1999.
Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative Research. Chicago: Aldine Publishing Co.; 1967.
Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: developing taxonomy, themes, and theory. Health Serv Res. 2007;42:1758–72.
Saldaña J. Longitudinal qualitative research: analyzing change through time. Walnut Creek: AltaMira Press; 2003.
Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data BMJ. 2000;320:114–6.
Jick TD. Mixing qualitative and quantitative methods: triangulation in action. Adm Sci Q. 1979;24:602–11.
Flieger SP, Spatz E, Cherlin EJ, Curry LA. Quality improvement initiatives to reduce mortality: an opportunity to engage palliative care and improve advance care planning. Am J Hosp Palliat Care. 2019;36:97–104.
O’Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods studies. BMJ. 2010;341: c4587.
Bisarya R, Song X, Salle J, Liu M, Patel A, Simpson SQ. Antibiotic timing and progression to septic shock among patients in the ED with suspected infection. Chest. 2022;161(1):112–20. https://doi.org/10.1016/j.chest.2021.06.029. Epub 2021 Jun 26.
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.
Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, et al. The timing of early antibiotics and hospital mortality in Sepsis. Am J Respir Crit Care Med. 2017;196:856–63.
Pruinelli L, Westra BL, Yadav P, Hoff A, Steinbach M, Kumar V, et al. Delay within the 3-hour surviving sepsis campaign guideline on mortality for patients with severe Sepsis and Septic shock. Crit Care Med. 2018;46:500–5.
Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for Sepsis. N Engl J Med. 2017;376:2235–44.
Whiles BB, Deis AS, Simpson SQ. increased time to initial antimicrobial administration is associated with progression to Septic shock in severe Sepsis patients. Crit Care Med. 2017;45:623–9.
Carriere KC, Roos LL. Comparing standardized rates of events. Am J Epidemiol. 1994;140:472–82.
Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1244–50.
Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care. 2003;19:613–23.
Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pediatr. 2013;13:S38-44.
Saeed S, Moodie EEM, Strumpf EC, Klein MB. Segmented generalized mixed effect models to evaluate health outcomes. Int J Public Health. 2018;63:547–51.
Sudman S, Bradburn NM, Schwarz N. Thinking about answers : the application of cognitive processes to survey methodology. San Francisco: Jossey-Bass Publishers; 1996.
Bergen N, Labonte R. “Everything Is Perfect, and We Have No Problems”: Detecting and limiting social desirability bias in qualitative research. Qual Health Res. 2020;30:783–92.
Creswell JW, Miller DL. Determining validity in qualitative inquiry. Theory Into Practice. 2000;39:124–30.
Denzin NK. Interpretive interactionism. Newbury Park, CA: Sage; 1989.
Bergdall A, Asche S, Schneider N, Kerby T, Margolis K, Sperl-Hillen J, et al. CB3–01: comparison of ethnicity and race categorization in electronic medical records and by self-report. Clin Med Res. 2012;10:172.
Klinger EV, Carlini SV, Gonzalez I, Hubert SS, Linder JA, Rigotti NA, et al. Accuracy of race, ethnicity, and language preference in an electronic health record. J Gen Intern Med. 2015;30:719–23.
Sholle ET, Pinheiro LC, Adekkanattu P, Davila MA, Johnson SB, Pathak J, et al. Underserved populations with missing race ethnicity data differ significantly from those with structured race/ethnicity documentation. J Am Med Inform Assoc. 2019;26:722–9.
Global Health Leadership Initiative. Organizational Culture Change. https://ysph.yale.edu/ghli/what/research/culture/. Accessed 15 Mar 2022.
We are grateful for the support of the Mayo Clinic Care Network team, and especially Sairey M Vitek and Richard C. Larsen, for their commitment to partnership and their critical feedback in the development of this approach. We also extend our gratitude to Emily Cherlin for her support in preparation of the manuscript.
This study is funded by a grant from the National Institute of General Medical Sciences to Yale University (1R01GM146463-01).
Ethics approval and consent to participate
This study was deemed exempt from continuing review by the institutional review board at Yale University under 45CFR46.104 (2)(iii), a determination that extends to the eight study sites. Informed consent procedures will be followed when recruiting each site to participate, and when inviting participants (guiding coalition members) to the survey and interviews. Clinical outcomes will be evaluated based on retrospective analysis of deidentified datasets from each participating site.
Consent for publication
Not applicable – There are no details on individuals reported within this prospective description of the study protocol.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1:
Supplemental Figure 1. Overview of study aims and sub-aims. Supplemental Figure 2. Examples of types of problems coalitions may prioritize. Supplemental Figure 3. Summary of evaluation approach, sampling, and analysis plans for each outcome. Supplemental Figure 4. Example of data integration to classify systems. Supplemental Figure 5. Example of trend analysis output.
Additional file 2:
Completed StaRI checklist.
Additional file 3:
Additional file 4:
Additional file 5:
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Linnander, E.L., Ayedun, A., Boatright, D. et al. Mitigating structural racism to reduce inequities in sepsis outcomes: a mixed methods, longitudinal intervention study. BMC Health Serv Res 22, 975 (2022). https://doi.org/10.1186/s12913-022-08331-5
- Structural Racism
- Organizational Culture
- Racial Disparities
- Intervention Studies
- Health Systems